Skip to content

Evaluating the analgesic effect and advantage of transcutaneous electrical acupoint stimulation for moderate to severe cancer-related pain in hepatocellular carcinoma

Evaluating the analgesic effect and advantage of transcutaneous electrical acupoint stimulation for moderate to severe cancer-related pain in hepatocellular carcinoma

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100044615
Enrollment
Unknown
Registered
2021-03-24
Start date
2021-04-01
Completion date
Unknown
Last updated
2022-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hepatocellular carcinoma

Interventions

Sponsors

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine. Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Participants match the diagnostic criteria for hepatocellular cancer established by the Union for International Cancer Control (UICC) [21]; 2.A numerical rating scale (NRS) score 4; 3.Aged 50-80years (either sex); 4.A Karnofsy performance state scale (KPS) score >= 60; 5.Patients have the ability to estimate themselves; 6.Able to understand the nature of the study and willing to give informed consent; 7.Written informed consent.

Exclusion criteria

Exclusion criteria: 1.Other physiological or pathological causes of pain; 2.Resection surgery performed within the last 3–6 months; 3.Serious acute or chronic organic diseases or psychiatric disorders; 4.Pregnancy or currently lactating; 5.Patients with skin lesions in local acupoints.

Design outcomes

Primary

MeasureTime frame
numerical rating scale;dosage and administration duration of opioid drugs;Brief Pain Inventory;

Secondary

MeasureTime frame
the Karnofsky Performance Status Scale ;Pittsburgh sleep quality index; Brief Fatigue Inventory ;

Countries

China

Contacts

Public ContactJing Li

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine. Shanghai University of Traditional Chinese Medicine

1971921250@qq.com+86 13918034508

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 12, 2026